臨床試驗

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NCT：NCT03554356 · ACTIVE_NOT_RECRUITING

NCT IDNCT03554356

狀態ACTIVE_NOT_RECRUITING

開始日期2018-09-04

SponsorUniversity of North Carolina, Chapel Hill (OTHER)

First posted2018-06-13

Last updated2026-09-14

簡要摘要

A multicenter, prospective, single arm, non randomized clinical trial to evaluate the safety and efficacy of the C2 CryoBalloon Focal Ablation System (CbFAS) for the treatment of persistent dysplasia or intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or \<50% eradication of Barrett's Esophagus (BE) after 2 RFA treatments.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。